Arming Vδ2 T Cells With Chimeric Antigen Receptors to Combat Cancer
Stemcell science news,
The authors present how arming Vδ2-T cells might be the basis for next-generation immunotherapies against solid tumors.
The authors present how arming Vδ2-T cells might be the basis for next-generation immunotherapies against solid tumors.
Following a comprehensive overview of γδ T cell biology and innovative CAR engineering strategies, investigators discuss the…